INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2014

Intestinal microbiota and fecal transplantation are implicated in regulating human glucose and lipid metabolism in insulin resistance and type 2 diabetes.

This review examines the role of intestinal microbiota and fecal transplantation in insulin resistance and type 2 diabetes mellitus. Alterations in intestinal microbiota composition promote systemic inflammation, which is a hallmark of obesity and subsequent insulin resistance. Fecal transplantation studies indicate that butyrate-producing intestinal bacteria are crucial key players in regulating diverse signaling cascades linked to human glucose and lipid metabolism.

Study type
Narrative review
Who was studied
Individuals with insulin resistance, obesity, and type 2 diabetes
What was measured
Glucose and lipid metabolism, systemic inflammation, insulin resistance

THE PAPER

Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus.

Udayappan SD, Hartstra AV, Dallinga-Thie GM, Nieuwdorp M. Clin Exp Immunol, 2014.

PubMed 24528224 ↗DOI 10.1053/j.gastro.2012.06.031 ↗

Diabetes & blood sugarGut & microbiomeWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.